nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Hypotensive—Furosemide—dilated cardiomyopathy	0.0378	0.0443	CcSEcCtD
Remifentanil—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.0296	0.0347	CcSEcCtD
Remifentanil—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.0272	0.0319	CcSEcCtD
Remifentanil—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0249	0.0292	CcSEcCtD
Remifentanil—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0214	0.0251	CcSEcCtD
Remifentanil—Heartburn—Lisinopril—dilated cardiomyopathy	0.015	0.0176	CcSEcCtD
Remifentanil—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.014	0.0164	CcSEcCtD
Remifentanil—Renal failure—Spironolactone—dilated cardiomyopathy	0.0139	0.0163	CcSEcCtD
Remifentanil—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.0135	0.0158	CcSEcCtD
Remifentanil—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0135	0.0158	CcSEcCtD
Remifentanil—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.0128	0.015	CcSEcCtD
Remifentanil—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0115	0.0134	CcSEcCtD
Remifentanil—Oliguria—Lisinopril—dilated cardiomyopathy	0.0112	0.0132	CcSEcCtD
Remifentanil—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.011	0.0129	CcSEcCtD
Remifentanil—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0102	0.0119	CcSEcCtD
Remifentanil—Urinary retention—Furosemide—dilated cardiomyopathy	0.00952	0.0112	CcSEcCtD
Remifentanil—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00921	0.0108	CcSEcCtD
Remifentanil—Confusional state—Spironolactone—dilated cardiomyopathy	0.00912	0.0107	CcSEcCtD
Remifentanil—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00911	0.0107	CcSEcCtD
Remifentanil—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00904	0.0106	CcSEcCtD
Remifentanil—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00885	0.0104	CcSEcCtD
Remifentanil—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00867	0.0102	CcSEcCtD
Remifentanil—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00859	0.0101	CcSEcCtD
Remifentanil—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00824	0.00966	CcSEcCtD
Remifentanil—Somnolence—Spironolactone—dilated cardiomyopathy	0.00804	0.00942	CcSEcCtD
Remifentanil—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00792	0.00929	CcSEcCtD
Remifentanil—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00789	0.00925	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00781	0.00915	CcSEcCtD
Remifentanil—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.0078	0.00914	CcSEcCtD
Remifentanil—Renal failure—Furosemide—dilated cardiomyopathy	0.00758	0.00889	CcSEcCtD
Remifentanil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00745	0.00873	CcSEcCtD
Remifentanil—Sweating—Furosemide—dilated cardiomyopathy	0.00739	0.00867	CcSEcCtD
Remifentanil—Urticaria—Spironolactone—dilated cardiomyopathy	0.00718	0.00842	CcSEcCtD
Remifentanil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00715	0.00838	CcSEcCtD
Remifentanil—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00714	0.00837	CcSEcCtD
Remifentanil—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00672	0.00787	CcSEcCtD
Remifentanil—Visual impairment—Furosemide—dilated cardiomyopathy	0.00667	0.00782	CcSEcCtD
Remifentanil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00666	0.00781	CcSEcCtD
Remifentanil—Pruritus—Spironolactone—dilated cardiomyopathy	0.0064	0.0075	CcSEcCtD
Remifentanil—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00638	0.00748	CcSEcCtD
Remifentanil—Angiopathy—Furosemide—dilated cardiomyopathy	0.00628	0.00736	CcSEcCtD
Remifentanil—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00625	0.00733	CcSEcCtD
Remifentanil—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00624	0.00732	CcSEcCtD
Remifentanil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00619	0.00725	CcSEcCtD
Remifentanil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00619	0.00725	CcSEcCtD
Remifentanil—Dysuria—Lisinopril—dilated cardiomyopathy	0.00607	0.00711	CcSEcCtD
Remifentanil—Erythema—Furosemide—dilated cardiomyopathy	0.00603	0.00706	CcSEcCtD
Remifentanil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00598	0.00701	CcSEcCtD
Remifentanil—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00585	0.00686	CcSEcCtD
Remifentanil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00582	0.00682	CcSEcCtD
Remifentanil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00575	0.00674	CcSEcCtD
Remifentanil—Rash—Spironolactone—dilated cardiomyopathy	0.0057	0.00668	CcSEcCtD
Remifentanil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0057	0.00667	CcSEcCtD
Remifentanil—Renal failure—Lisinopril—dilated cardiomyopathy	0.00569	0.00667	CcSEcCtD
Remifentanil—Headache—Spironolactone—dilated cardiomyopathy	0.00566	0.00664	CcSEcCtD
Remifentanil—Anaemia—Furosemide—dilated cardiomyopathy	0.00557	0.00653	CcSEcCtD
Remifentanil—Sweating—Lisinopril—dilated cardiomyopathy	0.00555	0.0065	CcSEcCtD
Remifentanil—Agitation—Furosemide—dilated cardiomyopathy	0.00554	0.00649	CcSEcCtD
Remifentanil—Haematuria—Lisinopril—dilated cardiomyopathy	0.00552	0.00647	CcSEcCtD
Remifentanil—Nausea—Spironolactone—dilated cardiomyopathy	0.00537	0.00629	CcSEcCtD
Remifentanil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00529	0.0062	CcSEcCtD
Remifentanil—Hallucination—Lisinopril—dilated cardiomyopathy	0.00517	0.00606	CcSEcCtD
Remifentanil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00516	0.00604	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0051	0.00597	CcSEcCtD
Remifentanil—Dry mouth—Furosemide—dilated cardiomyopathy	0.00502	0.00588	CcSEcCtD
Remifentanil—Confusional state—Furosemide—dilated cardiomyopathy	0.00496	0.00581	CcSEcCtD
Remifentanil—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00492	0.00576	CcSEcCtD
Remifentanil—Shock—Furosemide—dilated cardiomyopathy	0.00484	0.00567	CcSEcCtD
Remifentanil—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00482	0.00565	CcSEcCtD
Remifentanil—Flushing—Lisinopril—dilated cardiomyopathy	0.00482	0.00565	CcSEcCtD
Remifentanil—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00482	0.00564	CcSEcCtD
Remifentanil—Skin disorder—Furosemide—dilated cardiomyopathy	0.00478	0.0056	CcSEcCtD
Remifentanil—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00476	0.00557	CcSEcCtD
Remifentanil—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00471	0.00552	CcSEcCtD
Remifentanil—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00468	0.00549	CcSEcCtD
Remifentanil—Chills—Lisinopril—dilated cardiomyopathy	0.00466	0.00546	CcSEcCtD
Remifentanil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00464	0.00544	CcSEcCtD
Remifentanil—Hypotension—Furosemide—dilated cardiomyopathy	0.0046	0.00539	CcSEcCtD
Remifentanil—Erythema—Lisinopril—dilated cardiomyopathy	0.00452	0.0053	CcSEcCtD
Remifentanil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00442	0.00518	CcSEcCtD
Remifentanil—Somnolence—Furosemide—dilated cardiomyopathy	0.00437	0.00513	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00425	0.00498	CcSEcCtD
Remifentanil—Tremor—Lisinopril—dilated cardiomyopathy	0.00424	0.00497	CcSEcCtD
Remifentanil—Pain—Furosemide—dilated cardiomyopathy	0.00421	0.00493	CcSEcCtD
Remifentanil—Constipation—Furosemide—dilated cardiomyopathy	0.00421	0.00493	CcSEcCtD
Remifentanil—Anaemia—Lisinopril—dilated cardiomyopathy	0.00418	0.0049	CcSEcCtD
Remifentanil—Syncope—Lisinopril—dilated cardiomyopathy	0.00406	0.00475	CcSEcCtD
Remifentanil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00405	0.00475	CcSEcCtD
Remifentanil—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00397	0.00466	CcSEcCtD
Remifentanil—Cough—Lisinopril—dilated cardiomyopathy	0.00395	0.00462	CcSEcCtD
Remifentanil—Urticaria—Furosemide—dilated cardiomyopathy	0.00391	0.00458	CcSEcCtD
Remifentanil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00389	0.00456	CcSEcCtD
Remifentanil—Anxiety—Lisinopril—dilated cardiomyopathy	0.00384	0.0045	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00382	0.00448	CcSEcCtD
Remifentanil—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00378	0.0257	CbGpPWpGaD
Remifentanil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00377	0.00441	CcSEcCtD
Remifentanil—Confusional state—Lisinopril—dilated cardiomyopathy	0.00372	0.00436	CcSEcCtD
Remifentanil—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00369	0.00433	CcSEcCtD
Remifentanil—Oedema—Lisinopril—dilated cardiomyopathy	0.00369	0.00433	CcSEcCtD
Remifentanil—Shock—Lisinopril—dilated cardiomyopathy	0.00363	0.00426	CcSEcCtD
Remifentanil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00362	0.00425	CcSEcCtD
Remifentanil—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00361	0.00424	CcSEcCtD
Remifentanil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0036	0.00422	CcSEcCtD
Remifentanil—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00359	0.0042	CcSEcCtD
Remifentanil—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00357	0.00418	CcSEcCtD
Remifentanil—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00351	0.0239	CbGpPWpGaD
Remifentanil—Pruritus—Furosemide—dilated cardiomyopathy	0.00348	0.00408	CcSEcCtD
Remifentanil—Hypotension—Lisinopril—dilated cardiomyopathy	0.00345	0.00404	CcSEcCtD
Remifentanil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00337	0.00394	CcSEcCtD
Remifentanil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00331	0.00388	CcSEcCtD
Remifentanil—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00331	0.0226	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00331	0.0226	CbGpPWpGaD
Remifentanil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00329	0.00386	CcSEcCtD
Remifentanil—Somnolence—Lisinopril—dilated cardiomyopathy	0.00328	0.00385	CcSEcCtD
Remifentanil—Dizziness—Furosemide—dilated cardiomyopathy	0.00325	0.00381	CcSEcCtD
Remifentanil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00325	0.00381	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00319	0.00373	CcSEcCtD
Remifentanil—Constipation—Lisinopril—dilated cardiomyopathy	0.00316	0.0037	CcSEcCtD
Remifentanil—Pain—Lisinopril—dilated cardiomyopathy	0.00316	0.0037	CcSEcCtD
Remifentanil—Vomiting—Furosemide—dilated cardiomyopathy	0.00313	0.00367	CcSEcCtD
Remifentanil—Rash—Furosemide—dilated cardiomyopathy	0.0031	0.00363	CcSEcCtD
Remifentanil—Dermatitis—Furosemide—dilated cardiomyopathy	0.0031	0.00363	CcSEcCtD
Remifentanil—Headache—Furosemide—dilated cardiomyopathy	0.00308	0.00361	CcSEcCtD
Remifentanil—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00308	0.021	CbGpPWpGaD
Remifentanil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00304	0.00356	CcSEcCtD
Remifentanil—Urticaria—Lisinopril—dilated cardiomyopathy	0.00293	0.00344	CcSEcCtD
Remifentanil—Nausea—Furosemide—dilated cardiomyopathy	0.00292	0.00342	CcSEcCtD
Remifentanil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00292	0.00342	CcSEcCtD
Remifentanil—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0029	0.0198	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0029	0.0198	CbGpPWpGaD
Remifentanil—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0028	0.0191	CbGpPWpGaD
Remifentanil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00272	0.00319	CcSEcCtD
Remifentanil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00261	0.00306	CcSEcCtD
Remifentanil—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0026	0.0177	CbGpPWpGaD
Remifentanil—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00255	0.0174	CbGpPWpGaD
Remifentanil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00253	0.00296	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00245	0.0167	CbGpPWpGaD
Remifentanil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00244	0.00286	CcSEcCtD
Remifentanil—Vomiting—Lisinopril—dilated cardiomyopathy	0.00235	0.00275	CcSEcCtD
Remifentanil—Rash—Lisinopril—dilated cardiomyopathy	0.00233	0.00273	CcSEcCtD
Remifentanil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00232	0.00272	CcSEcCtD
Remifentanil—Headache—Lisinopril—dilated cardiomyopathy	0.00231	0.00271	CcSEcCtD
Remifentanil—Nausea—Lisinopril—dilated cardiomyopathy	0.00219	0.00257	CcSEcCtD
Remifentanil—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00215	0.0147	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00208	0.0142	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00202	0.0138	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00178	0.0121	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00178	0.0121	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00165	0.0113	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00156	0.0106	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00156	0.0106	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0015	0.0102	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0015	0.0102	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00145	0.00987	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00139	0.0095	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00139	0.00948	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00138	0.00942	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00137	0.00931	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00132	0.00897	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00132	0.00897	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00131	0.00896	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00131	0.00896	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00129	0.00881	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00125	0.00854	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00122	0.00834	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00122	0.00833	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00122	0.00831	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.0012	0.00817	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00119	0.00812	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00119	0.00812	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00113	0.00773	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00111	0.00757	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00111	0.00757	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00111	0.00755	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0011	0.00748	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00107	0.00731	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00107	0.00729	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00105	0.00712	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00105	0.00712	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00103	0.00704	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00103	0.00703	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00101	0.00692	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00101	0.0069	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000972	0.00662	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000961	0.00655	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000958	0.00653	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000941	0.00641	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000938	0.00639	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000928	0.00633	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000916	0.00625	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000908	0.00619	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000908	0.00619	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000899	0.00613	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00089	0.00606	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000883	0.00602	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000883	0.00602	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000869	0.00593	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000844	0.00575	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000843	0.00575	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000821	0.0056	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000817	0.00557	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000811	0.00553	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000804	0.00548	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000796	0.00542	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000796	0.00542	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000795	0.00542	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000793	0.0054	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000762	0.0052	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000752	0.00513	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00074	0.00504	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000716	0.00488	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000712	0.00486	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000711	0.00485	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000698	0.00476	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000679	0.00463	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000673	0.00458	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000673	0.00458	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000662	0.00451	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000645	0.0044	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000644	0.00439	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000625	0.00426	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000612	0.00417	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000606	0.00413	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000601	0.0041	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000581	0.00396	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000565	0.00385	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000517	0.00352	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000513	0.0035	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000513	0.0035	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000491	0.00335	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000491	0.00334	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000478	0.00326	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000477	0.00325	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000466	0.00317	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000466	0.00317	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000462	0.00315	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00045	0.00307	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00045	0.00307	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000433	0.00295	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000431	0.00293	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000419	0.00286	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000418	0.00285	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000408	0.00278	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000408	0.00278	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000405	0.00276	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000394	0.00269	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00038	0.00259	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00038	0.00259	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00038	0.00259	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000374	0.00255	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000368	0.00251	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000364	0.00248	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000358	0.00244	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000353	0.00241	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000346	0.00236	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000345	0.00235	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000345	0.00235	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000342	0.00233	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00034	0.00232	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000328	0.00224	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000321	0.00219	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000314	0.00214	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000311	0.00212	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00031	0.00211	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000298	0.00203	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000292	0.00199	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00029	0.00198	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000278	0.00189	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000277	0.00189	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000275	0.00188	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000275	0.00188	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000272	0.00185	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000265	0.00181	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000264	0.0018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000256	0.00174	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000255	0.00174	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000252	0.00172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000252	0.00172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000248	0.00169	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000243	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000241	0.00164	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000241	0.00164	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000231	0.00158	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00023	0.00157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000224	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000221	0.00151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000217	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000215	0.00147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000212	0.00144	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000206	0.0014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000204	0.00139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000204	0.00139	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000201	0.00137	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000195	0.00133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00019	0.00129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000187	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000186	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000184	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000176	0.0012	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000175	0.00119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000172	0.00118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000157	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000156	0.00106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000153	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000151	0.00103	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000149	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000149	0.00101	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000137	0.000931	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000131	0.00089	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00013	0.000883	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000128	0.000871	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00012	0.000817	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000115	0.000787	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00011	0.000752	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000105	0.000717	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000103	0.000704	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.06e-05	0.000617	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.89e-05	0.000606	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.66e-05	0.000522	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.09e-05	0.000483	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.21e-05	0.000423	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.25e-05	0.000358	CbGpPWpGaD
